Insights from Zebrafish and Mouse Models on the Activity and Safety of Ar-Turmerone as a Potential Drug Candidate for the Treatment of Epilepsy

• Adriana Monserrath Orellana-Paucar,

  Affiliations Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven, Belgium, Facultad de Ciencias Químicas, Escuela de Bioquímica y Farmacia, Universidad de Cuenca, Cuenca, Ecuador

  ⨯
• Tatiana Afrikanova,

  Affiliation Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven, Belgium

  ⨯
• Joice Thomas,

  Affiliation Laboratory for Molecular Design and Synthesis, Department of Chemistry, University of Leuven, Leuven, Belgium

  ⨯
• Yelaman K. Aibuldinov,

  Affiliation Laboratory for Molecular Design and Synthesis, Department of Chemistry, University of Leuven, Leuven, Belgium

  ⨯
• Wim Dehaen,

  Affiliation Laboratory for Molecular Design and Synthesis, Department of Chemistry, University of Leuven, Leuven, Belgium

  ⨯
• Peter A. M. de Witte,

  Affiliation Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven, Belgium

  ⨯
• Camila V. Esguerra

  * E-mail: camila.esguerra@pharm.kuleuven.be

  Affiliation Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven, Belgium

  ⨯